@article{993fb572f1ed4ec99c7304d31b5b3f98,
title = "Tetraploidy is associated with poor prognosis at diagnosis in multiple myeloma",
author = "Surbhi Sidana and Dragan Jevremovic and Ketterling, \{Rhett P.\} and Nidhi Tandon and Greipp, \{Patricia T.\} and Baughn, \{Linda B.\} and Angela Dispenzieri and Gertz, \{Morie A.\} and Rajkumar, \{Sundararajan Vincent\} and Kumar, \{Shaji K.\}",
note = "Funding Information: SS: Honoraria/consultancy: Janssen; AD: Consultant for Takeda; Research funding from Celgene, Takeda, Janssen; GlaxoSmithKline, Alnylam, and Pfizer; MAG: Honoraria/consultancy from Ionis, Alnylam, Prothena, Celgene, Janssen, Specytrum, Annexon, Apellis, Amgen, Medscape, Abbvie, Research to Practice, Physcians Education Resource and Teva; SKK: Research Funding and membership on an entity's Board of Directors or advisory committees: AbbVie, Celgene, Janssen KITE, Merck. Membership on an entity's Board of Directors",
year = "2019",
month = may,
doi = "10.1002/ajh.25420",
language = "English (US)",
volume = "94",
pages = "E117--E120",
journal = "American journal of hematology",
issn = "0361-8609",
publisher = "John Wiley and Sons Inc.",
number = "5",
}